Filing Flows

Filing Flows › Celldex Therapeutics (CLDX) › Who owns the stock

Who owns Celldex Therapeutics (CLDX) stock

242 funds reported Celldex Therapeutics (CLDX) shares in their latest 13F filings, worth $3.2B in all. The largest holder is Wellington Management Group LLP ($355M). Last quarter 144 funds added to their stakes and 69 cut them.

Largest holders of CLDX (13F)Largest holders of CLDX (13F)Wellington Management Group LLP$355MBlackRock$261MKynam Capital Management, LP$198MPrice T Rowe Associates$174MState Street$145MFMR LLC$139MVanguard Capital Management LLC$129MVanguard Group$109MDeep Track Capital, LP$109MLogos Global Management LP$78.1M

Largest holders (13F)

FundSharesValueChangeQuarter
Wellington Management Group LLP9,543,671$355Mincrease2026-06-30
BlackRock7,002,530$261Mincrease2026-06-30
Kynam Capital Management, LP5,322,908$198Mdecrease2026-06-30
Price T Rowe Associates4,685,223$174Mincrease2026-06-30
State Street3,900,427$145Mincrease2026-06-30
FMR LLC3,722,888$139Mdecrease2026-06-30
Vanguard Capital Management LLC3,464,831$129Mincrease2026-06-30
Vanguard Group4,027,407$109Mincrease2025-12-31
Deep Track Capital, LP2,939,151$109Mincrease2026-06-30
Logos Global Management LP2,100,000$78.1Mincrease2026-06-30
Geode Capital Management, LLC2,022,226$75.3Mincrease2026-06-30
Eversept Partners, LP1,785,941$66.5Mdecrease2026-06-30
Goldman Sachs Group1,615,343$60.1Mincrease2026-06-30
Commodore Capital LP1,350,000$50.2Mdecrease2026-06-30
Bellevue Group AG1,200,000$44.7Munchanged2026-06-30

Celldex Therapeutics' latest quarter

Celldex Therapeutics, Q2 2026: revenue $22K (-97% year over year), net loss $73.5M, operating cash flow −$57.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CLDX stock?

By the latest 13F filings: Wellington Management Group LLP ($355M); BlackRock ($261M); Kynam Capital Management, LP ($198M); Price T Rowe Associates ($174M); State Street ($145M).

What is the short interest in CLDX?

9,598,891 shares were sold short at the 2026-10-15 settlement, -12.79% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.